-
PDF
- Split View
-
Views
-
Cite
Cite
Philippe Meyer, Sophie Degrauwe, Christian Van Delden, Jelena-Rima Ghadri, Christian Templin, Typical takotsubo syndrome triggered by SARS-CoV-2 infection, European Heart Journal, Volume 41, Issue 19, 14 May 2020, Page 1860, https://doi.org/10.1093/eurheartj/ehaa306
- Share Icon Share
Takotsubo syndrome (TTS) is an important differential diagnosis of myocardial injury, which may play a significant role in the COVID-19 pandemic. This report describes a typical case of TTS triggered by SARS-CoV-2 infection.
An 83-year-old lady treated for chronic hypertension was hospitalized for acute chest pain on 18 March 2020, 21 days after the COVID-19 outbreak started in Geneva, Switzerland. She described a 5/10 oppressive mediosternal non-radiating chest discomfort associated with mild breathlessness and dry cough since 15 March. Physical examination was unremarkable. ECG (Panel A) showed <1 mm ST-segment elevation in all precordial leads with deep T-wave inversions. High-sensitive cardiac troponin T was elevated at 1142 ng/L (<14 ng/L). Chest X-ray did not detect any pulmonary opacity. Echocardiography revealed typical left ventricular apical ballooning with hyperkinetic basal segments. Coronary angiography showed non-significant lesions (Panel B) with a typical takotsubo syndrome (TTS) image on ventriculography (Panel C). At day 3, the patient started developing fever, showing increasing biological signs of inflammation, and clear bilateral lung X-ray opacities (Panel D). Nasopharyngeal swab was negative for SARS-CoV-2, but the initial positive immunoglobin A and negative immunoglobulin G serology pattern proved acute infection. The patient recovered progressively on conventional heart failure medication without the need for oxygen/ventilation, and echocardiography showed only mild residual apical hypokinesis on the day of discharge (day 10).
This is to our knowledge the first case of TTS described in the COVID-19 pandemic. The huge emotional stress at the population level and respiratory infections caused by COVID-19 may represent potential triggers in this context. Myocardial injury, frequently reported in patients with COVID-19, is usually attributed to sepsis and/or hypoxaemia and/or underlying coronary artery disease, as well as myocarditis. We believe that TTS may also play a significant role in the COVID-19 pandemic.
We would like to thank Nicolas Johner, MD who helped in designing the figure.
Authors’ contributions: all authors participated in writing and approved the final manuscript. Written consent for publication was obtained from the patient.